REAGENTS AND METHODS FOR AFFINITY PURIFICATIONS

Information

  • Research Project
  • 2004057
  • ApplicationId
    2004057
  • Core Project Number
    R44AI035343
  • Full Project Number
    2R44AI035343-02
  • Serial Number
    35343
  • FOA Number
  • Sub Project Id
  • Project Start Date
    1/1/1994 - 31 years ago
  • Project End Date
    8/31/1999 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1997 - 27 years ago
  • Budget End Date
    8/31/1998 - 26 years ago
  • Fiscal Year
    1997
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/19/1997 - 27 years ago
Organizations

REAGENTS AND METHODS FOR AFFINITY PURIFICATIONS

A project is proposed to continue development of reagents and methods for immobilizing ligands onto membranes for affinity purifications, by photoimmobilizing hydrophilic polymeric coupling reagents to which the ligands will be coupled. During the Phase I project and since that time, important advances have been made in reagents and methods for immobilizing antibodies and protein A onto membranes. Reagents and methods were developed that greatly increased the amount of active receptor immobilized. This method uses hydrophilic polymers having photoactivatable groups and multiple reactive groups for coupling to affinity ligands. The polymeric coupling reagents being developed are designed to form very open polymeric layers when immobilized, to allow penetration of the ligands to be immobilized into the layer and thereby achieve efficient coupling also having very low nonspecific adsorption of proteins from the solutions being purified. Although a small amount of further development of Protein A immobilization will be carried out during the Phase II project, the primary focus of this proposed project will be immobilization of heparin for affinity purification of a wide variety of proteins, including clotting factors, protease inhibitors, lipoproteins, growth factors, lipolytic enzymes, extracellular matrix proteins and viral coat proteins. Use of these methods for preparing affinity membranes is expected to increase the efficiency of the purification process, to improve the quality of such purified products and to reduce the costs of a variety of bioseparations. PROPOSED COMMERCIAL APPLICATION: This project is expected to result in techniques for producing improved affinity membranes for purifying proteins from plasma, genetically engineered cells or other sources. This is a rapidly growing market and membrane-based affinity purification is expected to become an increasingly important purification method.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R44
  • Administering IC
    AI
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    SURMODICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    EDEN PRAIRIE
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55344
  • Organization District
    UNITED STATES